Skip to main content

Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy | BioSpace

By July 6, 2020News
Avantor® Avantor

Avantor® Avantor

RADNOR, Pa., June 30, 2020 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced the expansion of the company’s Bridgewater, N.J. (USA) innovation center. Located close to biotech companies, the site now has nearly double the laboratory and support space.

Bioprocessing efficiency that doesn’t compromise quality continues to be a top priority for the biopharma industry. At the same time, it’s critical to meet increasingly stringent global regulatory standards.

 

{iframe}https://www.biospace.com/article/releases/avantor-expands-life-sciences-innovation-center-to-address-bioprocessing-needs-in-protein-science-monoclonal-antibodies-mabs-cell-and-gene-therapy/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.